These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37935785)

  • 1. Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission.
    Antuori A; Giménez M; Linares G; Cardona PJ
    Sci Rep; 2023 Nov; 13(1):19302. PubMed ID: 37935785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
    Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
    BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
    J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study.
    López-Herrero R; Sánchez-de Prada L; Tamayo-Velasco A; Lorenzo-López M; Gómez-Pesquera E; Sánchez-Quirós B; de la Varga-Martínez O; Gómez-Sánchez E; Resino S; Tamayo E; Álvaro-Meca A
    Eur J Public Health; 2023 Aug; 33(4):675-681. PubMed ID: 37087109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.
    Floridia M; Giuliano M; Monaco M; Palmieri L; Lo Noce C; Palamara AT; Pantosti A; Brusaferro S; Onder G;
    Antimicrob Resist Infect Control; 2022 May; 11(1):74. PubMed ID: 35598032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
    Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
    J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections.
    Duan Y; Wang J; Wang S; Zhang R; Hu J; Li W; Chen B
    Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):577-586. PubMed ID: 38246947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
    Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
    PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital.
    Lie KC; Shakinah S; Pasaribu A; Sinto R; Nainggolan L
    Acta Med Indones; 2022 Apr; 54(2):161-169. PubMed ID: 35818653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.
    Asmarawati TP; Rosyid AN; Suryantoro SD; Mahdi BA; Windradi C; Wulaningrum PA; Arifianto MV; Bramantono B; Triyono EA; Rusli M; Rachman BE; Marfiani E; Endraswari PD; Hadi U; Kuntaman K; Nasronudin N
    F1000Res; 2021; 10():113. PubMed ID: 33868645
    [No Abstract]   [Full Text] [Related]  

  • 20. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.